John Overdeck’s Opus Bank Common Stock OPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-185,963
Closed -$3.22M 3766
2020
Q1
$3.22M Buy
185,963
+22,877
+14% +$534K 0.03% 717
2019
Q4
$4.22M Buy
163,086
+149,055
+1,062% +$3.69M 0.01% 1070
2019
Q3
$305K Sell
14,031
-27,237
-66% -$578K ﹤0.01% 2956
2019
Q2
$871K Buy
41,268
+29,868
+262% +$630K ﹤0.01% 2052
2019
Q1
$226K Buy
+11,400
New +$242K ﹤0.01% 2757
2018
Q1
Sell
-10,500
Closed -$287K 3704
2017
Q4
$287K Sell
10,500
-60,354
-85% -$1.56M ﹤0.01% 2753
2017
Q3
$1.7M Buy
70,854
+50,554
+249% +$1.17M 0.01% 1396
2017
Q2
$491K Sell
20,300
-162,092
-89% -$3.57M ﹤0.01% 2347
2017
Q1
$3.67M Buy
182,392
+137,405
+305% +$3.14M 0.01% 1094
2016
Q4
$1.35M Buy
+44,987
New +$1.2M 0.01% 1783
2016
Q2
Sell
-68,430
Closed -$2.33M 3387
2016
Q1
$2.33M Sell
68,430
-165,678
-71% -$5.46M 0.01% 1102
2015
Q4
$8.65M Buy
234,108
+218,522
+1,402% +$8.22M 0.04% 473
2015
Q3
$596K Buy
15,586
+6,886
+79% +$258K ﹤0.01% 1457
2015
Q2
$315K Sell
8,700
-12,250
-58% -$395K ﹤0.01% 2400
2015
Q1
$647K Buy
+20,950
New +$593K ﹤0.01% 1833

John Overdeck's OPB Position: Q2 2020 in Review

John Overdeck sold out of Opus Bank Common Stock (OPB) in Q2 2020, closing a stake of 185,963 shares — an estimated $3.22M sold.

John Overdeck first reported a position in OPB in Q1 2015 and held it in 15 quarters. The position peaked at $8.65M in Q4 2015. 0 funds tracked by Wall St. Rank hold OPB as of Q2 2020.

  • John Overdeck reported no remaining Opus Bank Common Stock position as of Q2 2020 after selling out during the quarter.
  • John Overdeck sold 185,963 Opus Bank Common Stock shares in Q2 2020, an estimated $3.22M.
  • John Overdeck first reported a position in Opus Bank Common Stock in Q1 2015 and held it in 15 quarters.
  • John Overdeck's Opus Bank Common Stock position peaked at $8.65M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Opus Bank Common Stock as of Q2 2020.

Based on Two Sigma Investments's 13F filing for Q2 2020, filed 14 Aug 2020.